Key facts
- It has raised $76.8M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Shenzhen Capital Group, Addor Capital, Co-Stone Capital, Qianhai FoF, HT CC — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Intalight
- ·The full record, as it builds
Funding rounds
No funding rounds for Intalight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Intalight
Manufacturer and developer of ophthalmic Instruments designed for blood vessel medical imaging. The company's products scan and stitch together thousands of high-speed scanned images to form an enhanced picture of the patient's blood vessels, enabling ophthalmologists to make more accurate diagnoses.
- Sector
- Healthcare
- HQ
- Luoyang, China
- Founded
- 2014
- Employees
- 79
- Website
- intalight.com/
- Ownership
- Privately Held (backing)
Intalight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Intalight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Intalight in its N-PORT filings yet. We sweep new filings monthly.